Immunocore Limited Founded
Wednesday, October 1st, 2008MediGene AG and three private investors have founded Immunocore Ltd, which will focus on developing the technology platform for monoclonal T-cell receptors.
MediGene AG and three private investors have founded Immunocore Ltd, which will focus on developing the technology platform for monoclonal T-cell receptors.